SAN FRANCISCO / May 23, 2024 / Business Wire / Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today released its 2024 Physician Compensation Report. The report reveals that the average pay for doctors increased 5.9% in 2023 after a decline of 2.4% the previous year. The report also points to a 23% gender wage gap, with men physicians earning nearly $102,000 more than women physicians, even when controlling for specialty, location, and years of experience.
The report also includes new findings related to physician career satisfaction, including the impact of overwork, burnout, and the physician shortage. As these issues persist, half of all physicians surveyed reported they have thoughts about leaving clinical practice, and 86% are concerned about the U.S. health care system’s ability to care for an aging population.
“The U.S. health care system continues to face significant challenges that are taking a toll on even the most dedicated medical professionals,” said Nate Gross, MD, co-founder and chief strategy officer of Doximity. “Physicians are increasingly tasked with achieving more with less. The goal of this report is to empower physicians to advocate for themselves and make better-informed career decisions.”
With over 80% of U.S. physicians as members, Doximity maintains one of the largest physician compensation data sets in the U.S. The report includes compensation data from over 150,000 survey responses over the past five years, including responses from more than 33,000 full-time U.S. physicians in 2023 alone.
Report Highlights
Physician compensation and gender wage gap
Overwork, burnout and shortage
Read Doximity’s 2024 Physician Compensation Report.
About Doximity
Founded in 2010, Doximity is the leading digital platform for U.S. medical professionals. The company's network members include more than 80% of U.S. physicians across all specialties and practice areas. Doximity provides its verified clinical membership with digital tools built for medicine, enabling them to collaborate with colleagues, stay up to date with the latest medical news and research, manage their careers and on-call schedules, streamline documentation and administrative paperwork, and conduct virtual patient visits. Doximity's mission is to help doctors be more productive so they can provide better care for their patients.
Last Trade: | US$48.20 |
Daily Change: | 0.20 0.42 |
Daily Volume: | 2,105,894 |
Market Cap: | US$6.180B |
November 07, 2024 October 31, 2024 August 08, 2024 |
Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...
CLICK TO LEARN MORECue Biopharma is developing the first-ever class of therapeutics for the treatment of cancer that mimic the natural signals, or “Cues”, of the immune system. This novel class of injectable biologics selectively engages and modulates tumor-specific T cells directly within the patient’s body to transform...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB